Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7959905rdf:typepubmed:Citationlld:pubmed
pubmed-article:7959905lifeskim:mentionsumls-concept:C0439861lld:lifeskim
pubmed-article:7959905lifeskim:mentionsumls-concept:C0018183lld:lifeskim
pubmed-article:7959905lifeskim:mentionsumls-concept:C0431085lld:lifeskim
pubmed-article:7959905lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:7959905lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:7959905pubmed:issue1lld:pubmed
pubmed-article:7959905pubmed:dateCreated1994-12-12lld:pubmed
pubmed-article:7959905pubmed:abstractTextChemotactic activity of granulocytes attracted by tumor cells loaded either with anti-ganglioside monoclonal antibodies (mAb) or with antibody-glucose oxidase conjugates (mAb-GO) was investigated. The melanoma cell line SK-Mel-28 which expresses the ganglioside GD3 at high density as well as the neuroectodermal cell line SK-N-LO which expresses GD2 were used for the experiments. In the presence of 50% human AB-serum, antibody-loaded tumor cells induced chemotactic activity on granulocytes, probably due to the generation of C3a/C5a which could be detected in serum incubated with anti-GD3 loaded SK-Mel-28 cells. Both compounds could also be detected in vivo in the plasma of patients suffering from neuroblastoma during therapy with anti-GD2 antibodies. In another set of experiments mAb-GO conjugates generating high amounts of H2O2 in the presence of glucose were bound to these tumor cells. A significant lipid peroxidation could be observed in the simultaneous presence of iron and ascorbate. The lipid peroxidation products were measured as thiobarbituric acid-reactive substances (TBARS) and were also shown to induce chemotactic effects on granulocytes.lld:pubmed
pubmed-article:7959905pubmed:languageenglld:pubmed
pubmed-article:7959905pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7959905pubmed:citationSubsetIMlld:pubmed
pubmed-article:7959905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7959905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7959905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7959905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7959905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7959905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7959905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7959905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7959905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7959905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7959905pubmed:statusMEDLINElld:pubmed
pubmed-article:7959905pubmed:monthJunlld:pubmed
pubmed-article:7959905pubmed:issn0165-2478lld:pubmed
pubmed-article:7959905pubmed:authorpubmed-author:NiethammerDDlld:pubmed
pubmed-article:7959905pubmed:authorpubmed-author:RassnerGGlld:pubmed
pubmed-article:7959905pubmed:authorpubmed-author:MayerPPlld:pubmed
pubmed-article:7959905pubmed:authorpubmed-author:BrucheltGGlld:pubmed
pubmed-article:7959905pubmed:authorpubmed-author:FierlbeckGGlld:pubmed
pubmed-article:7959905pubmed:authorpubmed-author:Handgretinger...lld:pubmed
pubmed-article:7959905pubmed:authorpubmed-author:MeyleJJlld:pubmed
pubmed-article:7959905pubmed:authorpubmed-author:JeschkeBBlld:pubmed
pubmed-article:7959905pubmed:authorpubmed-author:SchaberBBlld:pubmed
pubmed-article:7959905pubmed:issnTypePrintlld:pubmed
pubmed-article:7959905pubmed:volume41lld:pubmed
pubmed-article:7959905pubmed:ownerNLMlld:pubmed
pubmed-article:7959905pubmed:authorsCompleteYlld:pubmed
pubmed-article:7959905pubmed:pagination67-71lld:pubmed
pubmed-article:7959905pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:meshHeadingpubmed-meshheading:7959905-...lld:pubmed
pubmed-article:7959905pubmed:year1994lld:pubmed
pubmed-article:7959905pubmed:articleTitleChemotactic activity of substances derived from antibody-loaded tumor cells on granulocytes.lld:pubmed
pubmed-article:7959905pubmed:affiliationDepartment of Dermatology, Children's Hospital, Tuebingen, Germany.lld:pubmed
pubmed-article:7959905pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7959905pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed